HYDROXYZINE (HYDROXYZINE HYDROCHLORIDE) — FDA Approval ANDA085551 (BAXTER HLTHCARE)
HYDROXYZINE (HYDROXYZINE HYDROCHLORIDE) — FDA Approval ANDA085551 (BAXTER HLTHCARE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROXYZINE; Active ingredients: HYDROXYZINE HYDROCHLORIDE; Application number: ANDA085551.
| Brand name | HYDROXYZINE |
|---|---|
| Active ingredients | HYDROXYZINE HYDROCHLORIDE |
| Application number | ANDA085551 |
| Sponsor | BAXTER HLTHCARE |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19790824 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →